This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_CORPUS_UTERI_EXALLC for full statistics.
Malignant neoplasm of corpus uteri
DOID EFO MESH SNOMED Endpoint Browser
C3_CORPUS_UTERI
endometrial carcinoma: A malignant tumor arising from the epithelium that lines the cavity of the uterine body. The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases. Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma. Uterine bleeding is an initial clinical sign. The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule
Sex
only females
239906
Check conditions None
239906
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C54
Cause of death: ICD-9
182
Cause of death: ICD-8
1820
Cancer registry: Topography ICD-O-3
C54
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
2150
Check minimum number of events None
2150
Include endpoints None
2150
Remove individuals based on genotype QC
2079
C3_CORPUS_UTERI
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of corpus uteri
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of corpus uteri (controls excluding all cancers)
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs (controls excluding all cancers)
- Malignant neoplasm (controls excluding all cancers)
- Malignant neoplasm
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2079 | 2079 | - |
| Unadjusted prevalence (%) | 0.50 | 0.90 | - |
| Mean age at first event (years) | 64.19 | 64.19 | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_CORPUS_UTERI – Malignant neoplasm of corpus uteri
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of corpus uteri
↥Endpoint not on priority list, no data to show.